An in-vivo method for testing drugs that influence striatal dopaminergic functions

Eric Y Fung, R. D. Schwarz

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A procedure is described for evaluating the effects of drugs on dopaminergic function in the striatum of mice. Mice, anesthetized with chloral hydrate are injected with 6-hydroxydopamine into one striatum to destroy dopamine nerve terminals at this site. Several days later, the mice are anesthetized with halothane, and test drugs or saline are injected into the intact striatum either before or after the systemic administration of amphetamine. The effect of these drugs on amphetamine-induced circling behavior is evaluated. Using this model, we have found that pilocarpine and muscimol can inhibit amphetamine-induced circling and their effects are blocked by the systemic administration of scopolamine and picrotoxin, respectively. In addition, ethyleneglycol-bis-(β-amino-ethyl ether) N,N′-tetraacetic acid (EGTA), a calcium chelating agent, inhibited amphetamine-induced circling behavior and this effect is prevented by adding calcium to the EGTA solution. Finally, the intrastriatal administration of prostaglandin E2 but not its metabolite, 13,14-dihydro-15-keto-prostaglandin 2 inhibited amphetamine-induced circling suggesting a selective effect of the active prostaglandin. These results suggest that this procedure could be used for evaluating both the mechanism of action of drugs in the striatum as well as screening drugs for their therapeutic potential.

Original languageEnglish (US)
Pages (from-to)231-234
Number of pages4
JournalPharmacology, Biochemistry and Behavior
Volume19
Issue number2
DOIs
StatePublished - Jan 1 1983

Fingerprint

Corpus Striatum
Amphetamine
Testing
Pharmaceutical Preparations
Egtazic Acid
Prostaglandins
Chloral Hydrate
Picrotoxin
Muscimol
Dopamine Agents
Preclinical Drug Evaluations
Pilocarpine
Scopolamine Hydrobromide
Oxidopamine
Halothane
Metabolites
Dinoprostone
Ether
Dopamine
Screening

Keywords

  • Circling behavior
  • Dopamine
  • Intrastriatal injection

ASJC Scopus subject areas

  • Biochemistry
  • Toxicology
  • Pharmacology
  • Clinical Biochemistry
  • Biological Psychiatry
  • Behavioral Neuroscience

Cite this

An in-vivo method for testing drugs that influence striatal dopaminergic functions. / Fung, Eric Y; Schwarz, R. D.

In: Pharmacology, Biochemistry and Behavior, Vol. 19, No. 2, 01.01.1983, p. 231-234.

Research output: Contribution to journalArticle

@article{504ea6a378a74d1e8edd05a4d4c07c47,
title = "An in-vivo method for testing drugs that influence striatal dopaminergic functions",
abstract = "A procedure is described for evaluating the effects of drugs on dopaminergic function in the striatum of mice. Mice, anesthetized with chloral hydrate are injected with 6-hydroxydopamine into one striatum to destroy dopamine nerve terminals at this site. Several days later, the mice are anesthetized with halothane, and test drugs or saline are injected into the intact striatum either before or after the systemic administration of amphetamine. The effect of these drugs on amphetamine-induced circling behavior is evaluated. Using this model, we have found that pilocarpine and muscimol can inhibit amphetamine-induced circling and their effects are blocked by the systemic administration of scopolamine and picrotoxin, respectively. In addition, ethyleneglycol-bis-(β-amino-ethyl ether) N,N′-tetraacetic acid (EGTA), a calcium chelating agent, inhibited amphetamine-induced circling behavior and this effect is prevented by adding calcium to the EGTA solution. Finally, the intrastriatal administration of prostaglandin E2 but not its metabolite, 13,14-dihydro-15-keto-prostaglandin 2 inhibited amphetamine-induced circling suggesting a selective effect of the active prostaglandin. These results suggest that this procedure could be used for evaluating both the mechanism of action of drugs in the striatum as well as screening drugs for their therapeutic potential.",
keywords = "Circling behavior, Dopamine, Intrastriatal injection",
author = "Fung, {Eric Y} and Schwarz, {R. D.}",
year = "1983",
month = "1",
day = "1",
doi = "10.1016/0091-3057(83)90044-8",
language = "English (US)",
volume = "19",
pages = "231--234",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - An in-vivo method for testing drugs that influence striatal dopaminergic functions

AU - Fung, Eric Y

AU - Schwarz, R. D.

PY - 1983/1/1

Y1 - 1983/1/1

N2 - A procedure is described for evaluating the effects of drugs on dopaminergic function in the striatum of mice. Mice, anesthetized with chloral hydrate are injected with 6-hydroxydopamine into one striatum to destroy dopamine nerve terminals at this site. Several days later, the mice are anesthetized with halothane, and test drugs or saline are injected into the intact striatum either before or after the systemic administration of amphetamine. The effect of these drugs on amphetamine-induced circling behavior is evaluated. Using this model, we have found that pilocarpine and muscimol can inhibit amphetamine-induced circling and their effects are blocked by the systemic administration of scopolamine and picrotoxin, respectively. In addition, ethyleneglycol-bis-(β-amino-ethyl ether) N,N′-tetraacetic acid (EGTA), a calcium chelating agent, inhibited amphetamine-induced circling behavior and this effect is prevented by adding calcium to the EGTA solution. Finally, the intrastriatal administration of prostaglandin E2 but not its metabolite, 13,14-dihydro-15-keto-prostaglandin 2 inhibited amphetamine-induced circling suggesting a selective effect of the active prostaglandin. These results suggest that this procedure could be used for evaluating both the mechanism of action of drugs in the striatum as well as screening drugs for their therapeutic potential.

AB - A procedure is described for evaluating the effects of drugs on dopaminergic function in the striatum of mice. Mice, anesthetized with chloral hydrate are injected with 6-hydroxydopamine into one striatum to destroy dopamine nerve terminals at this site. Several days later, the mice are anesthetized with halothane, and test drugs or saline are injected into the intact striatum either before or after the systemic administration of amphetamine. The effect of these drugs on amphetamine-induced circling behavior is evaluated. Using this model, we have found that pilocarpine and muscimol can inhibit amphetamine-induced circling and their effects are blocked by the systemic administration of scopolamine and picrotoxin, respectively. In addition, ethyleneglycol-bis-(β-amino-ethyl ether) N,N′-tetraacetic acid (EGTA), a calcium chelating agent, inhibited amphetamine-induced circling behavior and this effect is prevented by adding calcium to the EGTA solution. Finally, the intrastriatal administration of prostaglandin E2 but not its metabolite, 13,14-dihydro-15-keto-prostaglandin 2 inhibited amphetamine-induced circling suggesting a selective effect of the active prostaglandin. These results suggest that this procedure could be used for evaluating both the mechanism of action of drugs in the striatum as well as screening drugs for their therapeutic potential.

KW - Circling behavior

KW - Dopamine

KW - Intrastriatal injection

UR - http://www.scopus.com/inward/record.url?scp=0020556212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020556212&partnerID=8YFLogxK

U2 - 10.1016/0091-3057(83)90044-8

DO - 10.1016/0091-3057(83)90044-8

M3 - Article

VL - 19

SP - 231

EP - 234

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 2

ER -